Navigation Links
Karolinska Development AB Announces Publication of Year End Report for 2009

STOCKHOLM, March 15, 2010 /PRNewswire/ -- Karolinska Development AB announces publication of its Year End Report 2009 on the company's website.

    Key events during the year:


    October - December 2009

    - Revenue increased by 8.3 % to 6.9 (6.4) MSEK.
    - Operating income amounted to -22.1 (-249.0) MSEK.
    - Profit after tax amounted to -19.4 (-246.4) MSEK.
    - Income per share before dilution amounted to -0.71 (-10.15) SEK.
    - Investments in portfolio companies during the period amounted to 27.1
      (65.0) MSEK.
    - Cashflow during the period 322.3 (55.5) MSEK.
    - Value of the total portfolio according to the International Private
      Equity and Venture Capital Valuation Board (IPEV Valuation Board)
      guidelines has at the balance sheet date been estimated at 1,512.3 MSEK
      compared to 1,321.8 MSEK as of December 31, 2008.

    January - December 2009

    - Revenue increased by 30.5 % to 30.3 (23.2) MSEK.
    - Operating income amounted to -13.5 (-70.5) MSEK.
    - Profit after tax amounted to -2.6 (-57.7) MSEK.
    - Income per share before dilution amounted to -0.10 (-2.34) SEK.
    - Investments in portfolio companies during the period amounted to 172.4
      (148.6) MSEK.
    - Cash flow during the period amounted to 204.8 (180.3) MSEK.

    Parent company

    January - December 2009

    - Revenue increased by 116.1 % to 6.7 (3.1) MSEK.
    - Operating loss amounted to -101.1 (-61.5) MSEK.

The entire report is available on under Investors> Reports.

About Karolinska Development

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies. The portfolio includes a total of 19 potential first in class products.

    Conny Bogentoft
    CEO Karolinska Development
    Tel: +46(0)706-68-61-43,
    Karolinska Development AB (publ) 556707-5048

SOURCE Karolinska Development AB

Back to top
SOURCE Karolinska Development AB
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
2. 3 new honorary doctors at Karolinska Institutet
3. The Feinstein to collaborate with Swedens Karolinska Institute
4. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
5. Karolinska Development Invests in EvoStem Finland Oy
6. Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
7. Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing Portfolio
8. Michael J. Fox Receives Honorary Doctorate From Karolinska Institute
9. Michael J. Fox to be made honorary doctor at Karolinska Institutet
10. Isolation of a new gene family essential for early development
11. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, ... posters. This is one of Joplin's most famous and beautiful concert posters. The concert ... Michigan in Ann Arbor. The According to Hawley, "It is hard to believe that ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... to discuss bioavailability and the need to integrate dose form selection in early ... with OBN, the membership organization supporting and bringing together the UK’s emerging life ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the ... 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the ... Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention Center ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... AAIPharma Services Corp./Cambridge Major Laboratories, Inc. ... $15.8  Million to expand its laboratories and global ... The expansion will provide additional office space and ... of the pharmaceutical and biotechnology markets. ... up to 40,000 square feet of expanded development ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
Breaking Medicine Technology: